Related Experiment Videos
Fc receptors and their interaction with complement in autoimmunity
Reinhold E Schmidt1, J Engelbert Gessner
1Abteilung für Klinische Immunologie, Medizinische Hochschule Hannover, Labor für Molekulare Immunologie, Carl-Neuberg-Str. 1, Hannover 30625, Germany.
Immunology Letters
|August 30, 2005
Summary
Fc receptors (FcR) are key in autoimmune diseases. Inhibitory FcR suppress, while activating FcR promote disease, with complement component C5a mediating their interaction, offering a new therapeutic target.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Fc receptors (FcR) regulate immune responses by binding the Fc portion of antibodies.
- FcR exist as activating and inhibitory pairs, influencing antibody-mediated autoimmune diseases.
- FcgammaRIIB (inhibitory) suppresses, while FcgammaRIII (activating) promotes, autoimmune disease in mouse models.
Purpose of the Study:
- To review recent advances in FcR research, particularly from gene deletion studies in mice.
- To highlight the role of interacting factors, specifically complement component C5a, in FcR function during autoimmunity.
- To explore the therapeutic potential of the FcR-C5a interaction pathway.
Main Methods:
- Analysis of gene deletion studies in mouse models of autoimmunity.
- Review of emerging evidence on the role of complement component C5a.
- Investigation of the interaction between FcR and complement pathways.
Main Results:
- FcR play a critical role in antibody-mediated autoimmune diseases.
- Complement component C5a is essential for regulating FcR and sensing FcR-dependent responses.
- FcR and complement interact via C5a, linking regulation and effector functions in autoimmunity.
Conclusions:
- The FcR-C5a interaction pathway represents a promising therapeutic target for inflammatory and autoimmune diseases.
- Understanding FcR and complement interplay is crucial for developing novel treatments.
- Findings from mouse models suggest potential applicability to human autoimmune conditions.